Trademark Attorney / Law Firm

Daniel Levesque – Trademark Portfolio

Daniel Levesque specializes in Class 44 (Medical Services) trademark filings before the United States Patent and Trademark Office (USPTO), with 26 of 29 total filings concentrated in this category. The practice also covers Class 43 (Hotels & Restaurants) along with 2 other Nice Classification classes. Filing activity spans from 2015 to 2025. Currently, 4 trademarks are registered.

29 Total Trademarks
Loading...
By Date
By Name
Filter by Class:

Page 1 of 2 (29 results)

Practice Areas by Trademark Class

Daniel Levesque's trademark practice covers 2 Nice Classification classes, representing the range of industries and goods/services handled in their USPTO filings.

44
Medical Services (26 filings)

Medical services; veterinary services; hygienic and beauty care for human beings or animals

43
Hotels & Restaurants (3 filings)

Services for providing food and drink; temporary accommodation

Frequently Asked Questions

How many trademark applications has Daniel Levesque filed?

Daniel Levesque has filed 29 trademark applications with the United States Patent and Trademark Office (USPTO). Of these, 4 registered, 23 abandoned, 2 cancelled.

What trademark classes does Daniel Levesque specialize in?

Daniel Levesque has filed trademarks across 2 Nice Classification classes. The most common practice areas include Class 44 (Medical Services), Class 43 (Hotels & Restaurants). Class 44 covers medical services; veterinary services; hygienic and beauty care for human beings or animals.

How long has Daniel Levesque been filing trademarks?

Daniel Levesque's trademark filing history with the USPTO spans from 2015 to 2025, covering 10 years of trademark practice. During this period, Daniel Levesque has handled 29 trademark applications.

What is Daniel Levesque's trademark registration success rate?

Daniel Levesque has a 14% trademark registration rate, with 4 out of 29 resolved applications resulting in successful registration. Currently, 0 applications are pending review.